MedTrace Logo

Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms

NCT02449499 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-10-17

No results posted yet for this study

Summary

Depression and anxiety disorders, even when treated according to standard of care consisting of individual treatment with medication and/or therapy, can be associated with significant residual impact on quality of life. The purpose of this research is carry out an observational study of an existing clinical treatment, adjunctive interpersonally focused psychodynamic group therapy, to determine if this can improve quality of life for patients who have residual symptoms of chronic depression and anxiety.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Carrie Holmberg, MD, PhD · Stanford Psychiatry and Behavioral Science

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02449499 on ClinicalTrials.gov